Lineage Cell Therapeutics, Inc. (LCTX)

NYSEAMERICAN: LCTX · Real-Time Price · USD

1.350

+0.010 (0.75%)

At close: Sep 15, 2025, 4:00 PM EDT

1.360

+0.010 (0.74%)

Pre-market: Sep 16, 2025, 4:41 AM EDT

Lineage Cell Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Sep '25 Sep 15, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	308	111	191	199	413	264	Upgrade
Market Cap Growth	10.03%	-41.93%	-4.09%	-51.84%	56.44%	98.01%	Upgrade
Enterprise Value	268	79	151	134	349	228	Upgrade
Last Close Price	1.35	0.50	1.09	1.17	2.45	1.76	Upgrade
PS Ratio	27.32	11.66	21.32	13.53	95.13	144.57	Upgrade
PB Ratio	6.37	1.44	3.08	2.77	4.54	2.78	Upgrade
P/TBV Ratio	51.27	5.23	30.84	12.45	11.89	6.86	Upgrade
P/FCF Ratio	-	-	-	307.85	-	-	Upgrade
P/OCF Ratio	-	-	-	187.79	-	-	Upgrade
EV/Sales Ratio	24.57	8.36	16.88	9.11	80.50	124.70	Upgrade
EV/FCF Ratio	-	-	-	207.31	-	-	Upgrade
Debt / Equity Ratio	0.05	0.03	0.05	0.05	0.03	0.04	Upgrade
Debt / FCF Ratio	-	-	-	6.03	-	-	Upgrade
Asset Turnover	0.11	0.09	0.08	0.10	0.03	0.02	Upgrade
Quick Ratio	3.96	3.47	2.02	3.07	2.32	5.35	Upgrade
Current Ratio	4.08	3.65	2.14	3.16	2.37	5.66	Upgrade
Return on Equity (ROE)	-71.51%	-26.73%	-32.07%	-32.37%	-46.52%	-20.05%	Upgrade
Return on Assets (ROA)	-13.17%	-12.53%	-11.80%	-9.44%	-21.77%	-14.16%	Upgrade
Return on Capital (ROIC)	-21.41%	-18.58%	-18.82%	-16.61%	-31.93%	-15.35%	Upgrade
Earnings Yield	-13.27%	-16.80%	-11.27%	-13.21%	-10.42%	-7.82%	Upgrade
FCF Yield	-7.51%	-21.36%	-15.33%	0.33%	-5.79%	-7.51%	Upgrade
Buyback Yield / Dilution	-22.42%	-15.94%	-1.69%	-3.22%	-9.64%	-3.10%	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q